Cross-clade cytotoxic T cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and Thais

J Infect Dis. 1998 Oct;178(4):1040-6. doi: 10.1086/515652.

Abstract

A globally effective vaccine will need to elicit cytotoxic T lymphocytes (CTL) capable of recognizing diverse human immunodeficiency virus type 1 (HIV-1) clades. Study of the cellular immune responses of HIV-1-infected persons may allow predictions to be made regarding useful vaccine antigen components. The frequency and magnitude of CTL responses to clade E and B Gag, Pol-RT, Env, and Nef proteins were compared in 12 HLA-characterized, clade E-infected Thais and in 10 clade B-infected North Americans using vaccinia recombinant constructs for protein expression. While responses were detected against all proteins, they were most frequent and cross-reactive to Gag in both groups. Pol-RT was recognized less frequently in Thais than North Americans. Cross-clade protein recognition was common but not uniformly present among these HLA-disparate individuals. Population-specific CTL data are needed to adequately prepare for vaccine trials outside of North America and Europe.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Asian People / genetics
  • Black People / genetics
  • Black or African American
  • Cross Reactions
  • Florida
  • Gene Frequency
  • HIV Antigens / genetics
  • HIV Antigens / immunology*
  • HIV Infections / classification
  • HIV Infections / immunology*
  • HIV-1 / classification
  • HIV-1 / immunology*
  • HLA Antigens / genetics*
  • Humans
  • Racial Groups / genetics*
  • Recombinant Proteins / immunology
  • Serotyping
  • T-Lymphocytes, Cytotoxic / immunology*
  • Thailand
  • Vaccinia virus / genetics
  • White People / genetics

Substances

  • HIV Antigens
  • HLA Antigens
  • Recombinant Proteins